IL6 and serum lipopolysaccharide activity: These findings indicated that KCF18 exerts its therapeutic effects on endotoxemia-induced liver injury by modulating classical IL-6 signaling, inhibiting STAT3 and Akt activation as well as restoring vascular endothelial integrity.